Risk Factors for Treatment Failure with Oral Antivirals in HCV

Abstract

Introduction: Chronic hepatitis C virus (HCV) infection is one of the major cause of cirrhosis of liver and leads to significant morbidity and mortality. In past, HCV therapy was limited to subcutaneous peg interferon plus oral ribavirin, a regimen that was generally poorly tolerated and provided low efficacy, with cure rates below 40% for HCV genotypes 1 and 4, and below 75% for HCV genotypes 2 or 3. The availability of oral direct-acting antiviral (DAA) as treatment for chronic hepatitis C has revolutionized the field. Although current HCV therapies rarely fail to achieve viral eradication, a subset of patients experience treatment failure. Aim: To study the risk factors associated with treatment failure with oral antiviral drugs in patients of Chronic hepatitis C. Materials & Methods: It was a retrorospective study done at Medical Gastroenterology Department, PGIMS, Rohtak in which six years data i.e.from 01.01.2015 to 31.12.2020, pertainining to Eighty Six (86) chronic hepatitis C patients who had treatment failure i.e. SVR failure on oral antiviral drugs was analyzed. Observations: Out of the total 86 patients, there was clear cut male predominance i.e. 54 (62.79 %) with rural background (villages) i.e.73 (84.88%). The age distribution in these 86 patients varied between 10-80 yrs of age and characterstically peak was seen in 31-40 yrs age group i.e.25 patients (29.06 %). The majority of patients had high baseline HCV viral load (> 4 lakhs I.U. /ml) i.e. 52 patients (60.46%). Out of total 86 patients, , 50 patients (58.13%) were cirrhotic, 34 patients (39.53 %) were smokers, 33 patients (38.37%) were alcoholic, 26 patients (30.23 %) had past history of surgical intervention, 9 patients (10.46 %) were diabetic, 9 patients (10.46 %) had got tattoo, 8 patients (9.30%) had history of previous blood transfusion and 13 patients (15.11%) gave history of use of alternative medications. Results: The direct risk factors associated with development of failed SVR in HCV patients are high baseline HCV RNA viral load, cirrhosis, rural background and indirect risk factors are smoking, alcohol and Diabetes Mellitus but large scale studies in future are required to confirm the same.

Authors and Affiliations

Parveen Malhotra, Vani Malhotra, Yogesh Sanwariya, Dixit , Sahil Girdhar, Shailesh Rathee, Shinepreet Kaur, Sanjeet

Keywords

Related Articles

Response to Adjuvant Therapy of Granulomatous Lymphadenitis: Evidence from High Burden Country

Introduction: A granulomatous lymphadenitis is a form of inflammation of the lymph nodes that are often found. Until now, effective treatment of granulomatous lymphadenitis is still inconsistent, namely between surgical...

COVID-19 and Diabetes Mellitus: The Mechanisms of Potentially Fatal Comorbidity

It's known that Diabetes Mellitus (DM) can be a risky disease, full of complications if it's not controlled properly. These complications, along with the coronavirus disease 2019 (COVID-19) can be lethal due to suppressi...

VAC System Tortesanal: Alternative for the Treatment of Complex Wounds in the Absence of Commercialized Devices

Thevacuum-assistedclosure(VAC)techniqueisarelativelyrecentprocedurethatconsistsofadministeringnegativepressureonthewoundinconjunctionwithaclosedenvironmentthatdecreasesedema,facilitatingvascularization,oxygenationandheal...

The Relationship of Emotional Eating to Nutritional Adequacy Level in Women of Childbearing Age in Rimau Islands, Sumur Village, South Lampung

The group of women of childbearing age is one phase to prepare the next generation of quality. Inadequate food intake can cause Chronic Energy Deficiency problems in women of childbearing age....

Impact of a Physical Activities Program on Expenses with Hospitalization for Diabetes in the State of Pernambuco – Brazil

Background:The Health Gym Program (HGP) is the main program to promote health and physical activity in the public health system in Brazil. This intervention uses financial resources from the federal govern...

Download PDF file
  • EP ID EP714075
  • DOI 10.47191/ijmscrs/v2-i5-04
  • Views 46
  • Downloads 0

How To Cite

Parveen Malhotra, Vani Malhotra, Yogesh Sanwariya, Dixit, Sahil Girdhar, Shailesh Rathee, Shinepreet Kaur, Sanjeet (2022). Risk Factors for Treatment Failure with Oral Antivirals in HCV. International Journal Of Medical Science And Clinical Research Studies, 2(05), -. https://europub.co.uk./articles/-A-714075